Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04971278 · ClinicalTrials.gov registry record

Evaluating the Impact of a Supportive Care Program

A clinical trial of Patient Engagement and Morality, sponsored by NYU Langone Health.

Completed
Registry status
1,201
Enrollment target
1
Study location

NCT04971278 is a study of Patient Engagement and Morality that has completed, run by NYU Langone Health. The registered enrollment target is 1,201 participants, above the 189-participant average among 6 other Patient Engagement trials with a reported enrollment target (535% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04971278, a study of Patient Engagement and Morality, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
1,201 participants
Enrollment target
1
Study location

Study Summary

NYU's High Risk Program targets patients who may be more likely to have increased hospitalization due to health conditions that may cause death in the near future. Community Health Workers, a home visiting doctor service, a supportive care nurse, and behavioral health specialist engage the population to address a range of biopsychosocial needs with end goal in increasing support in the community and engaging palliative and hospice care when appropriate to prevent hospital readmissions, shorten length of stay, reduce hospital utilization, and decrease overall patient cost with a focus on hospital spend.

Interventions

  • BEHAVIORAL Supportive care program

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 1,201 participants
Start Date 2019-11-07
Est. Completion 2022-09-22

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT04971278

The ClinicalTrials.gov registry entry for NCT04971278 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,201 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 189-participant average among 6 other Patient Engagement trials with a reported enrollment target (535% higher). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Patient Engagement appearing as the primary indexed condition, and to 1 intervention - of which Supportive care program is the first listed.

NCT04971278 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04971278 about?

NCT04971278 is a clinical study titled "Evaluating the Impact of a Supportive Care Program". NYU's High Risk Program targets patients who may be more likely to have increased hospitalization due to health conditions that may cause death in the near future. Community Health Workers, a home visiting doctor service, a supportive care nurse, and behavioral health specialist engage the populatio...

What is the current status of trial NCT04971278?

This trial is currently completed. The enrollment target is 1,201 participants. The study started on 2019-11-07. Estimated completion is 2022-09-22.

What conditions does trial NCT04971278 study?

This clinical trial studies the following conditions: Patient Engagement, Morality.

What interventions are being tested in trial NCT04971278?

The interventions under investigation include: Supportive care program (BEHAVIORAL).

Who is sponsoring clinical trial NCT04971278?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04971278 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Patient Engagement

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.